Weekly Digests

2026

March

Neoantigen vaccination boosts long-lasting T cell responses in TNBC

March 11, 2026

Triple-negative breast cancer (TNBC) is characterized by DNA repair deficiency, genomic instability, and an immunogenic tumor microenvironment, suggesting it might serve as a candidate for individualized vaccination targeting somatic tumor mutation-associated neoantigens. Sahin, Schmidt, et al. recently published the results of a first-in-human clinical study with this strategy in Nature. To develop the...

AACR IO 2026

March 4, 2026

The ACIR team attended the AACR IO meeting held on February 18-21, 2026 in Los Angeles, CA, USA. This week’s extensive special feature covers select talks from the conference. We have organized the content by topics below. T cellsPhilip D. GreenbergRafi AhmedFred RamsdellAlexander MarsonRobert G. NewmanOwen N. Witte Checkpoint blockadeFathia Mami-ChouaiDario A. VignaliMegan...

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.